Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Jagsonpal Pharmaceuticals has informed that Meeting of Board of Directors of the Company will be held on Friday, the 13th Day of May, 2022, to consider and approve the alteration in the Articles of Association of the Company along with other routine matters.
The above information is a part of company’s filings submitted to BSE.